Target Name: LOC100128079
NCBI ID: G100128079
Review Report on LOC100128079 Target / Biomarker Content of Review Report on LOC100128079 Target / Biomarker
LOC100128079
Other Name(s): Uncharacterized LOC100128079 | uncharacterized LOC100128079

Introduction to LOC100128079
LOC100128079 is a gene that has gained significant attention in recent years due to its potential as a drug target or biomarker in a variety of diseases. This article aims to provide an in-depth understanding of LOC100128079 and its involvement in various biological processes.

What is LOC100128079?
LOC100128079, also known as long intergenic non-protein coding RNA 1663 (LINC01663), is a long non-coding RNA (lncRNA) gene located on chromosome 2. The exact function and mechanism of LOC100128079 are yet to be fully understood, but studies have suggested its involvement in several cellular processes.

Role in Cancer:
Cancer is a multifaceted disease with various genetic and epigenetic alterations. LOC100128079 has been found to play a crucial role in cancer development and progression. In breast cancer, for instance, higher expression of LOC100128079 has been associated with poor prognosis and advanced stages of the disease. This lncRNA promotes the proliferation and invasion of tumor cells by regulating key genes involved in these processes.

Impact on Neurological Disorders:
Neurological disorders, such as Alzheimer's and Parkinson's disease, have become increasingly prevalent in our aging population. Studies have suggested a potential link between LOC100128079 and these neurodegenerative diseases. In Alzheimer's disease, increased levels of LOC100128079 have been observed in brain tissues of patients, particularly in regions affected by neurodegeneration. Further research is needed to explore the exact mechanisms through which LOC100128079 influences these neurological disorders.

Involvement in Cardiovascular Health:
Cardiovascular diseases remain a leading cause of morbidity and mortality worldwide. Accumulating evidence indicates that LOC100128079 might play a role in cardiovascular health. In patients with heart failure, for example, increased expression of LOC100128079 has been associated with poor outcomes and an increased risk of adverse events. This lncRNA seems to modulate the expression of genes involved in cardiac remodeling and fibrosis.

LINC01663 as a Biomarker:
The identification of reliable biomarkers is crucial for early disease diagnosis, prognosis, and treatment response evaluation. LOC100128079 has shown promise as a potential biomarker in various diseases. In gastric cancer, high levels of LOC100128079 in plasma samples have been correlated with tumor progression and poor prognosis. Similarly, increased expression of LOC100128079 in urine samples has been associated with the presence and severity of diabetic kidney disease.

Therapeutic Target Potential:
Targeting LOC100128079 for therapeutic purposes is a relatively novel area of research. However, with increasing evidence of its involvement in various diseases, it has become an attractive target for the development of novel treatment strategies. Several approaches, including small molecule inhibitors and gene therapy techniques, are being explored to modulate the expression or function of LOC100128079. These strategies aim to disrupt its role in disease progression and potentially offer new therapeutic options for patients.

Conclusion:
LOC100128079, an lncRNA gene with still much to uncover, has emerged as a promising drug target or biomarker in various diseases. Its involvement in cancer, neurological disorders, cardiovascular health, and potential utility as a biomarker indicate its significance in understanding and potentially treating various conditions. Future research efforts will undoubtedly shed more light on the precise mechanisms and therapeutic potential of LOC100128079, opening new avenues for diagnosis, treatment, and improving patient outcomes.

Protein Name: Uncharacterized LOC100128079

The "LOC100128079 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100128079 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC100128093 | LOC100128164 | LOC100128242 | LOC100128288 | LOC100128317 | LOC100128361 | LOC100128398 | LOC100128494 | LOC100128593 | LOC100128770 | LOC100128966 | LOC100128988 | LOC100129034 | LOC100129098 | LOC100129148 | LOC100129175 | LOC100129203 | LOC100129215 | LOC100129316 | LOC100129381 | LOC100129434 | LOC100129455 | LOC100129534 | LOC100129603 | LOC100129697 | LOC100130000 | LOC100130207 | LOC100130285 | LOC100130298 | LOC100130331 | LOC100130452 | LOC100130463 | LOC100130548 | LOC100130587 | LOC100130691 | LOC100130698 | LOC100130744 | LOC100130748 | LOC100130872 | LOC100130899 | LOC100130938 | LOC100130987 | LOC100130992 | LOC100131096 | LOC100131107 | LOC100131257 | LOC100131289 | LOC100131372 | LOC100131496 | LOC100131532 | LOC100131626 | LOC100131635 | LOC100131859 | LOC100131877 | LOC100131943 | LOC100132004 | LOC100132062 | LOC100132077 | LOC100132078 | LOC100132249 | LOC100132287 | LOC100132356 | LOC100132609 | LOC100132626 | LOC100132651 | LOC100132686 | LOC100132741 | LOC100132781 | LOC100132797 | LOC100133077 | LOC100133165 | LOC100133177 | LOC100133284 | LOC100133331 | LOC100133920 | LOC100134317 | LOC100134368 | LOC100134391 | LOC100134868 | LOC100190986 | LOC100233156 | LOC100240728 | LOC100240734 | LOC100240735 | LOC100271840 | LOC100272216 | LOC100272217 | LOC100286922 | LOC100287036 | LOC100287290 | LOC100287329 | LOC100287413 | LOC100287792 | LOC100287834 | LOC100287846 | LOC100287944 | LOC100288069 | LOC100288162 | LOC100288208 | LOC100288637